For over 13 years Fugent has been the manufacturer of FuGENE® 6 transfection reagent, which has nearly 10,000 citations in scientific literature to date.* "FuGENE® 6 and our new transfection reagent FuGENE® HD are designed, developed and exclusively manufactured by Fugent LLC" says Vladimir Gurevich, President of Fugent LLC. Both FuGENE® 6 and FuGENE® HD demonstrate very high transfection efficiency with low toxicity and they have very simple protocols. FuGENE® transfection supports a breadth of Promega technologies including luciferase technologies used for cell-based assays.

"FuGENE® 6 is a leading transfection solution with trusted performance in a variety of cell model systems. Promega now has leading transfection tools for working with a myriad of biological systems, from standard cells and cancer models to primary and stem cells." says Kevin Kopish, Promega Strategic Marketing Manager. "This is also a perfect complement to Promega cell-based assays, especially with our Glo technology offerings."

Please visit www.promega.com/fugene for the latest information and to be contacted when FuGENE® 6 Transfection reagent is available from Promega.

FuGENE® 6 is a registered trademark of Fugent, LLC, USA.